Health Chain International Inc.
Everyone needs good health, and it requires all-around healthcare. Come True Biomedical, the parent company of Health Chain, which is listed in the Taipei Exchange, focuses its operation on the Asian market by initially leveraging genetic technologies and aggregating the expertise of medical doctors, dieticians, medical examiners and case managers, and provides accurate health management services and healthy products with the SNQ (Symbol of National Quality) logo and Halal certification to create a pan-Asia health protection network. Health Chain dedicates itself to promoting the health and wealth of people by providing a stable and excellent health-oriented entrepreneurial platform, developing new retail business and providing integrated health services to its members through the resources of the group to provide comprehensive health protection to the members. The purpose is to easily start a business and achieve a prosperous life while promoting good health.
Company address: 10F-6, No. 17, Chengteh Road, Section 1, Taitung District, Taipei City
Taiwan Branch of AXXA Global
AXXA Global firmly believes that a tiny seed can bring immense benefits to the people. A tiny seed holds the future of a tree. We believe that a seed contains the energy of a whole tree. AXXA Global creates excellent and highly effective products by using seeds, which have long been used since the ancient times, and state-of-the-art technologies and its proprietary and patented cold-press technology. While consuming excellent products, the consumers will realize that we provide extraordinary business opportunities and guide our partners to create a fashionable and ideal lifestyle. AXXA Global provides a global business platform to enable far-reaching business development.
Company address: 16F-2, No. 163, Keelung Road, Section 1, Hsinyi District, Taipei City
Successful Conclusion of the 2017 Training Forum for Seed Instructors of Code of Ethics
On August 4, the Direct Selling Association (DSA) conducted the 2017 Training Forum for Seed Instructors of Code of Ethics in Sherwood Hotel in Taipei. 40 seed instructors from various member companies gained a deeper understanding of the essence of the Code of Ethics and dispute resolution through case studies and exercises. They will also turn out to be the most important promotors of the Code of Ethics for the DSA.
Deputy Director Ching-tarng Lin of the Fair Trade Commission, who attended the event out of his busy schedule, not only recognized the positive effects of the Code of Ethics on the healthy development of the industry, but also commended the DSA's years of contribution to the promotion of the Code of Ethics. In this forum, Chairperson Tien-tsai Lin of the Society of Direct Selling Law and Chairperson Kuo-hsiung Chen of the Society of Direct Selling Management were invited to provide professional analysis concerning the interplay between the Code of Ethics and laws and regulations as well as the handling of disputes by member companies to kick off the wonderful breakout case study sessions on that day.
The Code of Ethics Committee designed four common dispute examples for the seed instructors with different roles played by various teams. To fully convey the positions and opinions of the participants, lively, funny and back-and-forth debates sometimes took place in the process. The 2017 Training Forum for Seed Instructors of Business Ethics came to an end in a joyful atmosphere. It is expected that more member representatives will follow in the footsteps of the seed instructors next year.
Instant access to relevant news!
Commercial Times: https://goo.gl/Aoeh2Z
NOWNEWS：https://goo.gl/mMgCnZ
Seminar on Administrative Regulations and Practical Operation of International Health Claims for Ord
Since the “Standard for Determining Exaggerative or Misleading Expressions or Medicinal Effects in Food Labels, Promotions” and “Advertisements and the Recommended Procedure for Sample Sentences for Illustrating Physiological Functions of Ordinary Nutrients” promulgated by the Ministry of Health and Welfare have had a major impact on the production of food advertisements, the Regulation Committee of the DSA organized a Seminar on Administrative Regulations and Practical Operation of International Health Claims for Ordinary Nutrients on July 28, 2017, by inviting Project Manager Ya-lan Yang of ILSI Taiwan, Deputy Research Technician Yi-hsuan Wu from the Food and Drug Administration of the Ministry of Health and Welfare, and Herbalife's Senior Manager Yi-teh Lin, to share their valuable expertise with representatives from member companies. The topics include the "comparison of international regulations on health claims with those in Taiwan," "sharing of experiences in sample sentences applied by companies for the description of nutrients," and "the recommended procedure and determination criteria for permitted sample sentences for health claims for ordinary nutrients and the guidelines for producing food advertisements." Representatives from member companies also seized the opportunity to exchange their views with the speakers and enjoyed wonderful experiences of positive interactions among the industry, government and academia.
Can Direct Selling Companies Sell Medical Devices?
According to the results of an annual survey announced by the Fair Trade Commission on the operation and development status of multilevel marketing enterprises, nutrition supplements are the mainstay of a direct selling company's products, followed by cosmetic and personal care products. The consumers of these products are typically health and beauty conscious. To attract purchases by more consumers, some direct selling companies also sell devices with similar efficacies. If such devices are medical devices under the Pharmaceutical Affairs Law, direct selling companies and distributors are required to follow the Pharmaceutical Affairs Law.
Under the Pharmaceutical Affairs Law, a "medical device" is an apparatus, instrument, implement, substance, software program, in vitro agent, and their relevant items which are used to diagnose, treat, reduce or directly prevent human diseases, or regulate birth, or which are sufficient to affect the structure and functions of human bodies, and which are applied to human bodies not by pharmacological, immunity or metabolic means to achieve their primary functions. To sell medical devices, a direct selling company should first determine if the products are medical devices pursuant to the Pharmaceutical Affairs Law and the Administrative Rules for Medical Devices. If they are medical devices, the category of the medical devices under the Administrative Rules for Medical Devices which the products fall under should then be determined before examination and registration of medical devices can be handled pursuant to different procedures. A license granted by the competent authority for a pharmaceutical operator should certainly be obtained first.
For example, "body fat monitors" are medical devices. A direct selling company seeking to import them to Taiwan is required to handle the examination and registration of the said medical devices first and receive a permit for such medical devices. In addition, a license for a pharmaceutical operator should be received before the medical devices may be sold. Otherwise, a person not complying with the relevant requirements is subject to imprisonment of up to three years and/or a fine of up to NT$10 million under the Pharmaceutical Affairs Law.
[Excerpted from the Practical Direct Selling Legal Issues]